Sigilon Therapeutics Inc. (SGTX): Price and Financial Metrics
SGTX Price/Volume Stats
| Current price | $22.47 | 52-week high | $28.00 |
| Prev. close | $23.06 | 52-week low | $3.77 |
| Day low | $22.09 | Volume | 83,600 |
| Day high | $23.10 | Avg. volume | 62,902 |
| 50-day MA | $14.79 | Dividend yield | N/A |
| 200-day MA | $9.81 | Market Cap | 56.49M |
SGTX Stock Price Chart Interactive Chart >
Sigilon Therapeutics Inc. (SGTX) Company Bio
Sigilon Therapeutics, Inc., a biopharmaceutical company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of the disease in patients with mucopolysaccharidosis type 1; and SIG-002 designed to replace islet cells for the treatment of type 1 diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
SGTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -38.27% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -87.32% |
| 2021 | -94.25% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...